THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPYActive

Company number 09664461Private company limited by guaranteeIncorporated 2015

Key figures

£22,824-19.8%
Net assets 2024/25
+11.1%
Average annual growth 2019/20–2024/25
010 k20 k30 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand13,46724,85531,23435,51822,431
Total assets17,57236,94748,55565,83625,077
Total liabilities2,83418,54922,94637,3822,253
Net assets / total equity14,73818,39825,60928,45422,824
Average number of employees87666

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY

Company

THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY is a private company limited by guarantee registered with Companies House under company number 09664461. It was incorporated on 30 Jun 2015. Its status is active. The registered office is in Manchester (M16). Its nature of business (SIC 2007) is activities of professional membership organizations (94120).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £22,824, down 19.8% on the previous year. Cash at bank and in hand was £22,431. Total assets were £25,077 and total liabilities £2,253. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2024/25).

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 14 Jul 2027.